Dextenza is an intracanalicular insert that delivers a 0.4mg dose of dexamethasone, a corticosteroid, for up to 30 days following insertion.

A statistically significantly lower risk of dementia or cognitive impairment was observed with GLP-1RAs, though not with SGLT2is or pioglitazone.

BeiGene has made the decision to end the clinical development program for ociperlimab (BGB-A1217) for the treatment of non-small cell lung cancer ...

Receipt of zoster vaccine reduces probability of new dementia diagnosis over seven-year period by 3.5 percentage points.

The Food and Drug Administration (FDA) has approved Uplizna ® (inebilizumab-cdon) for the treatment of immunoglobulin G4-related disease (IgG4-RD) in adult patients.

HealthDay News — For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON ...

Based on these findings, the USPSTF concludes that primary care behavioral counseling interventions to support breastfeeding have a moderate net benefit, with moderate certainty. Interventions or ...

HealthDay News — US Health Secretary Robert F. Kennedy Jr. says he will tell the US Centers for Disease Control and Prevention (CDC) to stop recommending fluoride in drinking water across the country.

Oz has made millions of dollars over the years selling dietary supplements and promoting health-related companies.